Influence of cyclic guanosine 3',5' monophosphate modulators on muscle contraction of rat aortas.
OBJECTIVE
The study examined the influence of probenecid (Pn), sildenafil (Sd) and oxidiazoloquinoxalin (ODQ) on contraction of phenylephrine (PhE) stimulated rat aortas.


METHODS
The study was performed at Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, Ernst-Moritz-Arndt University Greifswald, Greifswald, Germany, from 1st July to 30th September 2005. Thirty-five isolated rat aortas were stimulated with 10 microM PhE or preincubated for 30 minutes with 10 microM Pn, or 10 microM ODQ, or 50 microM Sd, and then incubated with 10 microM PhE in the presence or absence of the substances. The phosphorylated myosin light chain 20 was detected by using an antibody against phosphomyosin light chain 2.


RESULTS
The ratio of PhE stimulated phosphorylation of aortas (p<0.05) to the untreated was 16.7:1 at 30 seconds and 20.4:1 at 60 seconds. The stimulation decreased significantly at 120 seconds then during the following 10 minutes. Pre-incubation with 50 microM Sd (p>0.05) or 10 microM Pn (p<0.05) reduced the phosphorylation induced by PhE that was added to each for 30 seconds. But pre-incubation with 10 microM ODQ increased the phosphorylation brought about by addition of PhE for 60 seconds, p>0.05. The washout-effect of these modulators was not significant after stimulation with PhE only.


CONCLUSIONS
The study demonstrates the involvement of cyclic guanosine 3',5' monophosphate and its modulators on muscle contraction of rat aortas. Sildenafil and Pn reduced while oxidiazoloquinoxalin increased the contraction of rat aortas.
Mahmoud
Samira A
SA
Department of Pharmacology and Pharmaceutics, Faculty of Medicine and Health Sciences, University of Aden, Aden, Yemen. s_warfa22ye2002@yahoo.com
D000818:Animals; D001011:Aorta / Q000187:drug effects* / Q000502:physiology; D006152:Cyclic GMP / Q000494:pharmacology*; D004591:Electrophoresis, Polyacrylamide Gel; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009218:Myosins / Q000378:metabolism; D010766:Phosphorylation; D010879:Piperazines / Q000494:pharmacology; D011339:Probenecid / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology; D051381:Rats; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000494:pharmacology
D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate; D009218:Myosins; D006152:Cyclic GMP; D011339:Probenecid